Mechanism of Raf kinase inhibitor protein down-regulation in cancer

doi:10.3760/cma.j.issn.1673-422X.2015.10.008

Abstract

Wang Yun, Li Yuhong. Mechanism of Raf kinase inhibitor protein down-regulation in cancer[J]. Journal of International Oncology, 2015, 42(10): 750-752.

［1］ Al-Mulla F, Bitar MS, Taqi Z, et al. RKIP: much more than Raf kinase inhibitory protein［J］. J Cell Physiol, 2013, 228(8): 1688-1702. ［2］王越. Raf激酶抑制蛋白与恶性肿瘤［J］. 国际肿瘤学杂志, 2007, 34(1): 5-8. ［3］ Ren G, Baritaki S, Marathe H, et al. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer［J］. Cancer Res, 2012, 72(12): 3091-3104. ［4］ Zhang B, Wang O, Qin J, et al. cisacting elements and transacting factors in the transcriptional regulation of raf kinase inhibitory protein expression［J］. PLoS One, 2013, 8(12): e83097. ［5］ Beach S, Tang H, Park S, et al. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells［J］. Oncogene, 2008, 27(15): 2243-2248. ［6］ Guo W, Dong Z, Lin X, et al. Decreased expression and aberrant methylation of Raf kinase inhibitory protein gene in esophageal squamous cell carcinoma［J］. Cancer Invest, 2012, 30(10): 703-711. ［7］ AlMulla F, Hagan S, AlAli W, et al. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability［J］. J Clin Pathol, 2008, 61(4): 524-529. ［8］ Zlobec I, Bihl M, Foerster A, et al. Comprehensive analysis of CpG island methylator phenotype (CIMP)high, low, and negative colorectal cancers based on protein marker expression and molecular features［J］. J Pathol, 2011, 225(3): 336-343. ［9］ Doyle B, Hagan S, AlMulla F, et al. Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes′ B colorectal cancer patients［J］. Histopathology, 2013, 62(3): 505-510. ［10］ Minoo P, Zlobec I, Baker K, et al. Loss of raf1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer［J］. Am J Clin Pathol, 2007, 127(5): 820-827. ［11］ Martinho O, Gouveia A, Silva P, et al. Loss of RKIP expression is associated with poor survival in GISTs［J］. Virchows Arch, 2009, 455(3): 277-284. ［12］ Minoo P, Baker K, Goswami R, et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis［J］. Gut, 2006, 55(10): 1467-1474. ［13］ Huang L, Dai T, Lin X, et al. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells［J］. Biochem Biophys Res Commun, 2012, 425(2): 127-133. ［14］ Poma P, Labbozzetta M, Vivona N, et al. Analysis of possible mechanisms accounting for raf1 kinase inhibitor protein downregulation in hepatocellular carcinoma［J］. OMICS, 2012, 16(11): 579-588. ［15］ Li J, Wang Y, Song Y, et al. miR27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells［J］. Mol Cancer, 2014, 13: 193. ［16］ Selbach M, Schwanhusser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by microRNAs［J］. Nature, 2008, 455(7209): 58-63. ［17］ Schwanhusser B, Gossen M, Dittmar G, et al. Global analysis of cellular protein translation by pulsed SILAC［J］. Proteomics, 2009, 9(1): 205-209. ［18］ Burns KE, Darwin KH. Pupylation versus ubiquitylation: tagging for proteasomedependent degradation［J］. Cell Microbiol, 2010, 12(4): 424-431. ［19］ Emanuele MJ, Elia AE, Xu Q, et al. Global identification of modular cullinRING ligase substrates［J］. Cell, 2011, 147(2): 459-474. ［20］ Kim W, Bennett EJ, Huttlin EL, et al. Systematic and quantitative assessment of the ubiquitinmodified proteome［J］. Mol Cell, 2011, 44(2): 325-340. ［21］ Mandili G, Khadjavi A, Gallo V, et al. Characterization of the protein ubiquitination response induced by Doxorubicin［J］. FEBS J, 2012, 279(12): 2182-2191. ［22］ Guil S, Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together［J］. Int J Biochem Cell Biol, 2009, 41(1): 87-95. ［23］ Bernstein BE, Meissner A, Lander ES. The mammalian epigenome［J］. Cell, 2007, 128(4): 669-681. ［24］ Cano A, PérezMoreno MA, Rodrigo I, et al. The transcription factor snail controls epithelialmesenchymal transitions by repressing Ecadherin expression［J］. Nat Cell Biol, 2000, 2(2): 76-83. ［25］ Baritaki S, HuertaYepez S, Sahakyan A, et al. Mechanisms of nitric oxidemediated inhibition of EMT in cancer: inhibition of the metastasisinducer Snail and induction of the metastasissuppressor RKIP［J］. Cell Cycle, 2010, 9(24): 4931-4940. ［26］ Yook JI, Li XY, Ota I, et al. Wntdependent regulation of the Ecadherin repressor snail［J］. J Biol Chem, 2005, 280(12): 11740-11748. ［27］ Baritaki S, Yeung K, Palladino M, et al. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI0052 in tumor cell chemoimmunosensitization［J］. Cancer Res, 2009, 69(21): 8376-8385. ［28］ Bonavida B, Baritaki S. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NFkappaB/Snail/YY1/RKIP/PTEN Circuitry［J］. Crit Rev Oncog, 2011, 16(34): 211-226. ［29］ Baritaki S, Bonavida B. Viral infection and cancer: the NFkappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes［J］. Crit Rev Immunol, 2010, 30(1): 31-46.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.

Mechanism of Raf kinase inhibitor protein down-regulation in cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments